Nomination committee for the AGM 2024

In accordance with the decision at Pandox’s annual general meeting in 2023, Pandox’s nomination committee for the annual general meeting 2024 shall consist of members appointed by the four, per 31 July 2023 by votes, largest shareholders according to the shareholders’ register held by Euroclear Sweden, and the chairman of the board. The chairman of the board shall also summon the first meeting of the nomination committee. If a shareholder, who is entitled to appoint a representative to the nomination committee, abstains from appointing a representative, the right to appoint a representative shall pass to the largest shareholder who was previously not entitled to appoint a representative to the nomination committee. In line with the above, Helene Sundt AB and Christian Sundt AB have appointed a joint representative in the nomination committee. The member appointed by the largest shareholder by votes shall be appointed chairman of the nomination committee. The composition of the nomination committee shall be publicly announced no later than six months before the next annual general meeting. No remuneration shall be payable.

The nomination committee has been formed in accordance with the principles adopted by the annual general meeting and has the following composition:

- Anders Ryssdal, Eiendomsspar AS (Chairman of the nomination committee)

- Leiv Askvig, Helene Sundt AB and Christian Sundt AB jointly

- Christian Ringnes, Chairman of the board of Pandox AB (publ)

- Dick Bergqvist, AMF

- Camilla Wirth, Alecta

The proposals of the nomination committee will be presented in the notice of the annual general meeting for 2024 and will be published on Pandox’s website. The annual general meeting will be held in Stockholm 10 April, 2024.